Penumbra (PEN): Q4 Earnings Preview
Key Metrics
* Revenue: Analysts estimate $311.7 million, a 9.5% YoY increase
* Adjusted EPS: $0.89
Recent Performance
* Beat revenue estimates by 1.3% in Q3
* Exceeded top-line expectations by an average of 1.8% over the past two years
Analyst Outlook
* Estimates have been largely reconfirmed in the past 30 days
Industry Context
* Intuitive Surgical: 25.2% YoY revenue growth, beating estimates by 6.5%
* QuidelOrtho: 4.7% revenue decline, topping estimates by 1.4%
Economic Environment
* Inflation trending towards the Fed's 2% target
* Recent rate cuts and political developments have boosted market performance
* Healthcare equipment and supplies sector has underperformed with average share price declines of 2.3%
Stock Performance
* Penumbra's stock price remains unchanged heading into earnings
* Average analyst price target: $267.44, below the current share price ($268.67)
Investment Insight
* Enterprise software stocks leveraging generative AI capabilities may emerge as promising investments
* Special Free Report available on a profitable, growth-oriented enterprise software company embracing automation and AI